Sarepta Therapeutics (SRPT) Operating Income: 2012-2025
Historic Operating Income for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to -$300.4 million.
- Sarepta Therapeutics' Operating Income fell 42751.07% to -$300.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$117.2 million, marking a year-over-year decrease of 408.55%. This contributed to the annual value of $218.1 million for FY2024, which is 181.43% up from last year.
- According to the latest figures from Q2 2025, Sarepta Therapeutics' Operating Income is -$300.4 million, which was down 285.79% from $161.7 million recorded in Q4 2024.
- Over the past 5 years, Sarepta Therapeutics' Operating Income peaked at $161.7 million during Q4 2024, and registered a low of -$300.4 million during Q2 2025.
- In the last 3 years, Sarepta Therapeutics' Operating Income had a median value of -$701,000 in 2024 and averaged -$38.9 million.
- Its Operating Income has fluctuated over the past 5 years, first skyrocketed by 556.57% in 2024, then plummeted by 42,751.07% in 2025.
- Quarterly analysis of 5 years shows Sarepta Therapeutics' Operating Income stood at -$105.8 million in 2021, then dropped by 0.96% to -$106.8 million in 2022, then spiked by 123.05% to $24.6 million in 2023, then soared by 556.57% to $161.7 million in 2024, then tumbled by 42,751.07% to -$300.4 million in 2025.
- Its Operating Income stands at -$300.4 million for Q2 2025, versus $161.7 million for Q4 2024 and $22.2 million for Q3 2024.